EVOQ Remedies Ltd (EVOQ)

Currency in INR
3.96
+0.18(+4.76%)
Closed·
EVOQ Scorecard
Full Analysis
RSI suggests the stock is in oversold territory
EVOQ is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.963.96
52 wk Range
2.119.64
Key Statistics
Bid/Ask
3.96 / 3.96
Prev. Close
3.78
Open
3.96
Day's Range
3.96-3.96
52 wk Range
2.11-9.64
Volume
16K
Average Volume (3m)
52.68K
1-Year Change
-60.42%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EVOQ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

EVOQ Remedies Ltd Company Profile

Evoq Remedies Limited engages in the marketing, trading, and distribution of pharmaceutical formulations in India. The company trades in sweeteners, such as acesulfame potassium, aspartem, dextrose, erythritol, euro vanillin powder, malodextrin, miglitol, etc.; amino acids, such as L- alanine, L-arginine, L-aspartic acid, L-carnitine, L-cystine, L-glutamic acids, L-glutamine, L-glutathione, L-glycine, L-isoleucine, LL-trytophan, L-tyrosine, L-lysine, N-acetyl, and L-andystine; excipients, which include aspartem, bronopol, cross carmellous sodium, cross povidone, ethyl olliate, hard peraffin, hpmc all grades, light liquid paraffin, mannitol, menthol crystal, etc.; neutraceuticals; and opthalamics, which include atropine sulphate, bimatoprost, brimonidine, bromfenac, cyclopentolate, dorzolamide fluoromethelone, flurbiprofen, gatifloxacin, ketorolac tromethamine, latanoprost, natamycin, nepafenac, olopatadine, sulphacetamide sodium, timolol meleate, etc. It also offers ointments, such as adapalene, allantoin, avobenzone, azealic acid, calamine, chlorocresol, cetrimide, clindamycin phoshphate, clobetasol propionate, clotrimazole, cream base, cyclosporine, fluocinolol acetonide, fusidic acid, gamabenzene, gentamycin sulphate, halobetasol, hydroquinone, etc.; and oncology drugs, such as abiraterone acetate, alfuzosin, anastrazole, axitinib, azacitidine, bicalutamide, bleomycin, bosutinib, busualphan, capcitabine, carboplatin, cisplatin, etc. It also offers anti-biotic drugs, anti-malarial drugs, anti-allergic, anti cold drugs, analgesic/ anti-pyretic, anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants, and injections. In addition, it provides vitamins, dairy and spice products, sterile, active pharmaceutical ingredients, and veterinary feed products. The company was incorporated in 2010 and is based in Ahmedabad, India.

0
Market
India

Compare EVOQ to Peers and Sector

Metrics to compare
EVOQ
Peers
Sector
Relationship
P/E Ratio
106.7x6.3x−0.5x
PEG Ratio
−1.210.060.00
Price/Book
0.2x1.1x2.6x
Price / LTM Sales
0.7x0.9x3.3x
Upside (Analyst Target)
-0.0%43.5%
Fair Value Upside
Unlock7.9%6.3%Unlock

Earnings

Latest Release
Apr 10, 2025
EPS / Forecast
0.90 / --
Revenue / Forecast
141.61M / --
EPS Revisions
Last 90 days

EVOQ Income Statement

People Also Watch

128.15
UNBK
-0.69%
29.00
UCBK
+0.03%
260.65
KARU
-1.12%
253.00
REDI
+0.44%
107.60
CNBK
-0.14%

FAQ

What Stock Exchange Does EVOQ Remedies Trade On?

EVOQ Remedies is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for EVOQ Remedies?

The stock symbol for EVOQ Remedies is "EVOQ."

What Is the EVOQ Remedies Market Cap?

As of today, EVOQ Remedies market cap is 94.12M.

What Is EVOQ Remedies's Earnings Per Share (TTM)?

The EVOQ Remedies EPS (TTM) is 0.04.

From a Technical Analysis Perspective, Is EVOQ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has EVOQ Remedies Stock Split?

EVOQ Remedies has split 0 times.

How Many Employees Does EVOQ Remedies Have?

EVOQ Remedies has 0 employees.

What is the current trading status of EVOQ Remedies (EVOQ)?

As of 05 Aug 2025, EVOQ Remedies (EVOQ) is trading at a price of 3.96, with a previous close of 3.78. The stock has fluctuated within a day range of 3.96 to 3.96, while its 52-week range spans from 2.11 to 9.64.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.